J R ANDERSON - JoVE Visualize

Showing results (361-370 of 407) with videos related to

Pageof 41

Sort By:

Experimental Hematology|December 1, 1995

Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.

Cancer|December 26, 2001

Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study GroupD O Walterhouse, A S Pappo, K S Baker, et al.

The New England Journal of Medicine|March 10, 1983

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.

Sarcoma|June 4, 2008

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment ProtocolsR B Raney, H M Maurer, J R Anderson, et al.

Journal of Pediatric Hematology/Oncology|February 16, 2002

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study VR B Raney, J R Anderson, F G Barr, et al.

Medical and Pediatric Oncology|January 1, 1994

Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.

Cancer|November 1, 1990

A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.

The EMBO Journal|June 6, 1998

Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lensD T Gilmour, G J Lyon, M B Carlton, et al.

Medical and Pediatric Oncology|June 8, 2000

Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991R B Raney, J R Anderson, J Kollath, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000

Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IVK S Baker, J R Anderson, M P Link, et al.

Pageof 41

Showing results (361-370 of 407) with videos related to

Sort By:

Pageof 41

Experimental Hematology|December 1, 1995

Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.

Cancer|December 26, 2001

Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study GroupD O Walterhouse, A S Pappo, K S Baker, et al.

The New England Journal of Medicine|March 10, 1983

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.

Sarcoma|June 4, 2008

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment ProtocolsR B Raney, H M Maurer, J R Anderson, et al.

Journal of Pediatric Hematology/Oncology|February 16, 2002

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study VR B Raney, J R Anderson, F G Barr, et al.

Medical and Pediatric Oncology|January 1, 1994

Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.

Cancer|November 1, 1990

A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.

The EMBO Journal|June 6, 1998

Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lensD T Gilmour, G J Lyon, M B Carlton, et al.

Medical and Pediatric Oncology|June 8, 2000

Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991R B Raney, J R Anderson, J Kollath, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000

Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IVK S Baker, J R Anderson, M P Link, et al.

Pageof 41